FR2978033B1 - Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion - Google Patents

Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion

Info

Publication number
FR2978033B1
FR2978033B1 FR1156657A FR1156657A FR2978033B1 FR 2978033 B1 FR2978033 B1 FR 2978033B1 FR 1156657 A FR1156657 A FR 1156657A FR 1156657 A FR1156657 A FR 1156657A FR 2978033 B1 FR2978033 B1 FR 2978033B1
Authority
FR
France
Prior art keywords
salt
multivalent cation
treating human
halogenic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1156657A
Other languages
English (en)
Other versions
FR2978033A1 (fr
Inventor
Odile Aubrun
Bruno Biatry
Stanbury Laure Ramos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1156657A priority Critical patent/FR2978033B1/fr
Priority to PCT/EP2012/061876 priority patent/WO2013013902A2/fr
Publication of FR2978033A1 publication Critical patent/FR2978033A1/fr
Application granted granted Critical
Publication of FR2978033B1 publication Critical patent/FR2978033B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/884—Sequential application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
FR1156657A 2011-07-22 2011-07-22 Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion Expired - Fee Related FR2978033B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1156657A FR2978033B1 (fr) 2011-07-22 2011-07-22 Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion
PCT/EP2012/061876 WO2013013902A2 (fr) 2011-07-22 2012-06-20 Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1156657A FR2978033B1 (fr) 2011-07-22 2011-07-22 Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion

Publications (2)

Publication Number Publication Date
FR2978033A1 FR2978033A1 (fr) 2013-01-25
FR2978033B1 true FR2978033B1 (fr) 2013-07-12

Family

ID=45001902

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1156657A Expired - Fee Related FR2978033B1 (fr) 2011-07-22 2011-07-22 Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion

Country Status (1)

Country Link
FR (1) FR2978033B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021011204A (es) * 2019-03-18 2021-10-22 Unilever Ip Holdings B V Una composicion antitranspirante que comprende sales reactivas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940062B1 (fr) * 2008-12-19 2011-02-11 Oreal Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes

Also Published As

Publication number Publication date
FR2978033A1 (fr) 2013-01-25

Similar Documents

Publication Publication Date Title
WO2018112446A3 (fr) Utilisation de gènes à médiation par motif apoe4 pour le diagnostic et le traitement de la maladie d'alzheimer
CL2015001599A1 (es) Compuestos derivados de (piridin o pirimidin)-(piperidina o piperazina) sustituidos o sus sales, inhibidores de la colesterol 24-hidroxilasa (ch24h); medicamento; metodo de inhibicion de la ch24h; metodo para prevenir o tratar; y uso para la prevencion o tratamiento de epilepsia, alzheimer y parkinson, entre otras enfermedades.
SG10201811841UA (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
TR201905477T4 (tr) Nano-parçacık bileşimler.
CR20110128A (es) Metodos, sistemas y productos para predecir la respuesta de las celulas tumorales a un agente terapeutico y tratar a un paciente de acuerdo con la respuesta predicha
RU2018145985A (ru) Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
EA201291195A1 (ru) Усовершенствованная терапия рака на основе опухолеассоциированных антигенов, полученных из циклина d1
BR112013030492A2 (pt) método para produzir um produto de tecido, produto de tecido produzido por um processo, método de tratamento, e sistema de tratamento
WO2013013902A3 (fr) Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion
EP2755721A4 (fr) Système et méthode de traitement de la peau et des tissus sous-jacents pour améliorer leur santé, leur fonction et/ou leur aspect
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
BR112015011679A2 (pt) almofada portátil
BR112015006393A2 (pt) método para produzir um produto de tecido, produto de tecido produzido por um processo, e método de tratamento
AR092899A1 (es) Uso de masitinib para el tratamiento del cancer en subpoblaciones de pacientes identificados que utilizan factores de prediccion
BR112016018205A8 (pt) métodos de tratamento de mal de alzheimer, de seleção de pacientes, de identificação de pacientes, de previsão, de otimização da eficácia terapêutica, kit, uso de agente e uso in vitro de agente
MY159171A (en) Hair dyeing agent, hair dyeing product combination, and its use method
MX358991B (es) Uso de moleculas de enlace a la semaforina-4d para promover la neurogenesis despues de la apoplejia.
WO2013013999A3 (fr) Utilisation, comme anti-transpirant, d'un sel de cation multivalent sans anti-transpirant de type halogénure d'aluminium ou composé apte à réagir avec ledit sel afin de produire un effet anti-transpirant
MX2018009189A (es) Compuestos de anillo de siete miembros de pirimidina.
EA201490701A1 (ru) Композиции антиперспирантов и способ уменьшения потоотделения
AR094241A1 (es) Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos
MX356933B (es) Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
MX367811B (es) D-metadona para el tratamiento de síntomas psiquiátricos.
FR2978032B1 (fr) Procede de traitement de la transpiration humaine utilisant un halogenure de cation multivalent et un sel non azote d'anion
WO2016042561A3 (fr) Freination du mir-132 pour le traitement de troubles lipidiques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20210305